Anxiety News and Research

Latest Anxiety News and Research

Screening can help overcome barriers to mental health care among African-American youth

Mental health screening has been demonstrated to successfully connect African-American middle school students from a predominantly low-income area with school-based mental health services, according to results of a new study led by the TeenScreen National Center for Mental Health Checkups at Columbia University. The study was published in a recent online early edition of the Community Mental Health Journal.

16 Jun 2011

Study finds no link between anxiety, depression and weight loss after bariatric surgery

Depression and anxiety do not seem to interfere with the amount of weight loss or the improvement of obesity-related conditions after bariatric surgery, according to a new study of more than 25,000 patients presented here at the 28th Annual Meeting of the American Society for Metabolic & Bariatric Surgery.

16 Jun 2011

Train the brain to manage chronic pain

How do you function when chronic pain is a part of your daily life? The UC San Diego Center for Mindfulness (UCSD CFM) at UC San Diego Health System offers a novel program to help people who are dealing with chronic pain "train their brains" to lessen their experience of discomfort and, in some cases, eliminate it.

16 Jun 2011

ViroPharma receives European Centralized Marketing Authorization for Cinryze for treatment of HAE

ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.

16 Jun 2011

Bariatric surgery reduces incidence and severity of migraines

Bariatric surgery can lead to total or partial alleviation of migraines in nearly 90 percent of morbidly obese patients diagnosed with migraine headaches, according to a new study presented here at the 28th Annual Meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS).

15 Jun 2011

Scientists zero in on dose levels of "sacred mushroom"

Scientists at the Johns Hopkins University School of Medicine have zeroed in on the dose levels of the "sacred mushroom" chemical capable of yielding positive, life-changing experiences, while minimizing the chance of transient negative reactions in screened volunteers under supportive, carefully monitored conditions.

15 Jun 2011

Botox injections can reduce wrinkles with half as many sessions after 20 months

Patients receiving Botox Cosmetic treatments can reduce wrinkles with half as many sessions after 20 months, according to research conducted at Oregon Health & Science University's Casey Eye Institute.

15 Jun 2011

Study: Early intervention can reduce recurrences, prevent psychosis

Schizophrenia is a chronic illness that most often comes on in late adolescence or young adulthood and can devastate patients' lives. Many physicians and researchers believe that early intervention can increase the chances for recovery, reduce recurrences and even prevent the warning signs of psychosis from progressing to the actual disease.

15 Jun 2011

Newborn neurons help create emotional context of memory

Fear burns memories into our brain, and new research by University of California, Berkeley, neuroscientists explains how.

15 Jun 2011

Study links sleep duration with pressure to maintain thin body among adolescent girls

Sleep duration has a significant association with feelings of external pressure to obtain or maintain a thin body among adolescent girls, especially those who are white, suggests a research abstract that will be presented Tuesday, June 14, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC.

14 Jun 2011

Cypress receives FDA approval for ZUTRIPRO, REZIRA NDA to treat cough and common cold

Cypress Pharmaceutical announced today that the Food and Drug Administration (FDA) approved a new drug application (NDA) for ZUTRIPRO Oral Solution (CIII) and REZIRA Oral Solution.

14 Jun 2011

Smoking ban in NSW prison

In a new directive, prisoners at the Lithgow jail in central western New South Wales will be banned from smoking in their cells as part of a six-month trial to begin next year.

13 Jun 2011

Frontal cerebral thermal transfer can eliminate insomnia symptoms

People with primary insomnia may be able to find relief by wearing a cap that cools the brain during sleep, suggests a research abstract that will be presented Monday, June 13, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC (APSS).

13 Jun 2011

Survey reveals increase in drinking, cannabis use and psychological distress

The latest survey of Ontario adults from the Centre for Addiction and Mental Health (CAMH) shows increasing rates of daily drinking and cannabis use and high levels of psychological distress. The results of the 2009 CAMH Monitor survey, the longest running survey tracking mental health and addiction indicators among adults in Ontario, were published today.

13 Jun 2011

Patients with multiple sclerosis can benefit from group therapy sessions

Offering Multiple Sclerosis sufferers emotional support through group therapy sessions could improve their quality of life and save the NHS almost £500 per patient, a study at The University of Nottingham has discovered.

13 Jun 2011

Risky behavior, psychiatric disorders and substance abuse contribute to opioid overdose

Deaths related to prescription opioid therapy are under intense scrutiny, prompting those in pain medicine-clinicians, patient advocates, and regulators-to understand the causes behind avoidable mortality in legitimately treated patients.

13 Jun 2011

Spanish scale measures concern about cancer in healthy people

When a person has a family history of cancer, their worry about developing the disease may lead to them refusing to have preventive tests. Advice from genetic counselling units reduces their anxiety but, until now, nobody knew how much. Now, a scientific team has validated the 'Escala de Preocupaci-n por el C-ncer - EPC' (equivalent of the Cancer Worry Scale), the first of its kind in the Spanish language, in order to evaluate it.

10 Jun 2011

Abbott reports positive interim results from LCIG Phase III open-label study for advanced Parkinson's disease

Interim efficacy and safety results from a long-term, 54-week, Phase III open-label study of Abbott's investigational treatment for advanced Parkinson's disease showed that patients treated with levodopa-carbidopa intestinal gel (LCIG) for 12 weeks reported a decrease in "off" time and an increase in "on" time without troublesome dyskinesias.

9 Jun 2011

University of Mississippi grants ChromaDex global rights to pterostilbene

ChromaDex Corp. and the University of Mississippi today announced the university has granted the natural products company the exclusive worldwide patent rights to a potential new therapeutic use for pterostilbene (tero-STILL-bean) as an anxiolytic or anti-anxiety agent. ChromaDex' pTeroPure® is an ultra-pure formulation of pterostilbene, a compound found in blueberries and demonstrated to have multiple health benefits.

9 Jun 2011

Articles on health trajectories now available in Nursing Research journal

Health care research typically focuses on final outcomes such as cure or death—overlooking the fact that health and illness are dynamic states that evolve and change over time. A special collection of articles on health trajectory research is now available in a supplement to Nursing Research, official journal of the Eastern Nursing Research Society and the Western Institute of Nursing.

8 Jun 2011